A Review on the Role of Annexin Family in Triple-Negative Breast Cancer

Hao Fang1, Yuwei Guo2

  • 1Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011 China.

Insights

Triple-negative breast cancer (TNBC) is aggressive. Annexin family proteins are key in TNBC development, offering potential diagnostic and therapeutic targets for this challenging cancer subtype.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to its high malignancy and poor patient prognosis.
  • The Annexin protein family has emerged as a critical player in the biological processes underlying TNBC development and progression.

Purpose of the Study:

  • To comprehensively review the current research on Annexin family members in TNBC.
  • To elucidate the expression patterns, mechanisms of action, and clinical significance of Annexins in TNBC.
  • To identify potential therapeutic targets within the Annexin family for improved TNBC diagnosis and treatment.

Main Methods:

  • Literature review of peer-reviewed articles and research studies.
  • Analysis of existing data on Annexin expression in TNBC tissues.
  • Synthesis of information regarding the functional roles and clinical implications of Annexin family members.

Main Results:

  • Annexin family members exhibit varied expression levels in TNBC, correlating with disease characteristics.
  • Specific Annexins play crucial roles in TNBC cell proliferation, migration, and invasion.
  • The clinical significance of Annexin expression as a prognostic or predictive biomarker is under investigation.

Conclusions:

  • The Annexin family represents a promising area for novel therapeutic strategies against TNBC.
  • Further research into Annexin function and clinical relevance may lead to improved diagnostic tools and targeted treatments for TNBC patients.